Literature DB >> 12553423

Three-dimensional structure of the transthyretin-retinol-binding protein complex.

Hugo L Monaco1.   

Abstract

Transthyretin (TTR), formerly called prealbumin, one of the transporters of the hormone thyroxine and retinol-binding protein (RBP), the specific carrier of vitamin A, forms, under physiological conditions, a macromolecular complex that prevents glomerular filtration of the low-molecular-weight RBP in the kidneys. This paper describes briefly the three-dimensional structure of the two proteins as determined by X-ray diffraction analysis of single crystals and that of the complex that the two molecules form in plasma and discusses the non-crystallographic evidence that supports the model of the macromolecular complex.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12553423     DOI: 10.1515/CCLM.2002.213

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  13 in total

1.  Pharmacological inhibition of lipofuscin accumulation in the retina as a therapeutic strategy for dry AMD treatment.

Authors:  Konstantin Petrukhin
Journal:  Drug Discov Today Ther Strateg       Date:  2013

Review 2.  Disorder-to-order conformational transitions in protein structure and its relationship to disease.

Authors:  Paola Mendoza-Espinosa; Victor García-González; Abel Moreno; Rolando Castillo; Jaime Mas-Oliva
Journal:  Mol Cell Biochem       Date:  2009-04-09       Impact factor: 3.396

Review 3.  The molecular aspects of absorption and metabolism of carotenoids and retinoids in vertebrates.

Authors:  Made Airanthi K Widjaja-Adhi; Marcin Golczak
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2019-11-23       Impact factor: 4.698

4.  Retinol binding protein: marker for insulin resistance and inflammation postburn?

Authors:  Robert Kraft; David N Herndon; Gabriela A Kulp; Gabriel A Mecott; Heiko Trentzsch; Marc G Jeschke
Journal:  JPEN J Parenter Enteral Nutr       Date:  2011-11       Impact factor: 4.016

5.  Bicyclic [3.3.0]-Octahydrocyclopenta[c]pyrrolo Antagonists of Retinol Binding Protein 4: Potential Treatment of Atrophic Age-Related Macular Degeneration and Stargardt Disease.

Authors:  Christopher L Cioffi; Boglarka Racz; Emily E Freeman; Michael P Conlon; Ping Chen; Douglas G Stafford; Daniel M C Schwarz; Lei Zhu; Douglas B Kitchen; Keith D Barnes; Nicoleta Dobri; Enrique Michelotti; Charles L Cywin; William H Martin; Paul G Pearson; Graham Johnson; Konstantin Petrukhin
Journal:  J Med Chem       Date:  2015-08-04       Impact factor: 7.446

6.  Design, synthesis, and evaluation of nonretinoid retinol binding protein 4 antagonists for the potential treatment of atrophic age-related macular degeneration and Stargardt disease.

Authors:  Christopher L Cioffi; Nicoleta Dobri; Emily E Freeman; Michael P Conlon; Ping Chen; Douglas G Stafford; Daniel M C Schwarz; Kathy C Golden; Lei Zhu; Douglas B Kitchen; Keith D Barnes; Boglarka Racz; Qiong Qin; Enrique Michelotti; Charles L Cywin; William H Martin; Paul G Pearson; Graham Johnson; Konstantin Petrukhin
Journal:  J Med Chem       Date:  2014-09-11       Impact factor: 7.446

Review 7.  Transthyretin and the brain re-visited: is neuronal synthesis of transthyretin protective in Alzheimer's disease?

Authors:  Xinyi Li; Joel N Buxbaum
Journal:  Mol Neurodegener       Date:  2011-11-23       Impact factor: 14.195

Review 8.  Mechanism of Action and Clinical Application of Tafamidis in Hereditary Transthyretin Amyloidosis.

Authors:  Teresa Coelho; Giampaolo Merlini; Christine E Bulawa; James A Fleming; Daniel P Judge; Jeffery W Kelly; Mathew S Maurer; Violaine Planté-Bordeneuve; Richard Labaudinière; Rajiv Mundayat; Steve Riley; Ilise Lombardo; Pedro Huertas
Journal:  Neurol Ther       Date:  2016-02-19

9.  Transthyretin chemical chaperoning by flavonoids: Structure-activity insights towards the design of potent amyloidosis inhibitors.

Authors:  Nelson Ferreira; Alda Pereira-Henriques; Maria Rosário Almeida
Journal:  Biochem Biophys Rep       Date:  2015-08-01

10.  Discovery of Bispecific Antagonists of Retinol Binding Protein 4 That Stabilize Transthyretin Tetramers: Scaffolding Hopping, Optimization, and Preclinical Pharmacological Evaluation as a Potential Therapy for Two Common Age-Related Comorbidities.

Authors:  Christopher L Cioffi; Parthasarathy Muthuraman; Arun Raja; Andras Varadi; Boglarka Racz; Konstantin Petrukhin
Journal:  J Med Chem       Date:  2020-09-17       Impact factor: 8.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.